Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Regeneron Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
REGN
Nasdaq
8731
https://www.regeneron.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Regeneron Pharmaceuticals Inc
Biotech Stock Roundup: REGN, SAGE, NMRA Down on Updates, ITCI Gains on Study Success
- Apr 18th, 2024 5:55 pm
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
- Apr 17th, 2024 1:00 pm
Why Regeneron (REGN) Could Beat Earnings Estimates Again
- Apr 16th, 2024 4:10 pm
UPDATE 1-Regeneron to defend against DOJ complaint on drug-price manipulation
- Apr 15th, 2024 11:59 pm
Regeneron to defend against DOJ complaint on drug-price manipulation
- Apr 15th, 2024 11:24 pm
Regeneron to defend US Justice Department's complaint on drug-pricing manipulation
- Apr 15th, 2024 11:20 pm
Regeneron commits $500M to new venture capital fund
- Apr 15th, 2024 11:45 am
Antitrust fervor is gripping Washington and Silicon Valley. But lawsuits have been declining.
- Apr 15th, 2024 8:46 am
Regeneron (REGN) Accused of Fraudulent Practices Related to Eylea
- Apr 12th, 2024 5:54 pm
These Stocks Moved the Most Today: CarMax, Apple, Fastenal, Rivian, Alpine Immune, Nike, Robinhood, Constellation Brands, and More
- Apr 11th, 2024 8:43 pm
Stocks to Watch Thursday: Robinhood, Alpine Immune, Constellation Brands
- Apr 11th, 2024 5:59 pm
Are Regeneron's Legal Troubles — And Six-Week Slide — A Buying Opportunity?
- Apr 11th, 2024 5:01 pm
Dow Jones Lower Despite PPI Inflation Relief; Nvidia, Microsoft Price Targets Raised
- Apr 11th, 2024 2:27 pm
US sues Regeneron, alleging false price reporting on Eylea
- Apr 11th, 2024 11:06 am
US accuses Regeneron of fraudulent price reporting for eye drug
- Apr 10th, 2024 8:59 pm
UPDATE 2-US accuses Regeneron of fraudulent price reporting for eye drug
- Apr 10th, 2024 8:52 pm
An Intrinsic Calculation For Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Suggests It's 47% Undervalued
- Apr 10th, 2024 1:00 pm
EXEL or REGN: Which Is the Better Value Stock Right Now?
- Apr 9th, 2024 3:40 pm
11 Best Biotech ETFs To Buy
- Apr 9th, 2024 11:37 am
Linvoseltamab Pivotal Data Presented at AACR Reinforce High Response Rate that Deepens Over Time in Patients with Heavily Pre-Treated Multiple Myeloma
- Apr 7th, 2024 8:00 pm
Scroll